Purchase Short-Term Access
Simvastatin reduced major vascular events at 5 years in at-risk patients; benefits were maintained at 11 years
Edward P. Havranek, MD
Annals of Internal Medicine 2012;156:JC3-5.
doi:10.7326/0003-4819-156-6-201202210-02005
Purchase Online access to this article for 24 hours
